Biostax Corp. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/82df156a-3624-4bcb-98ef-e3532dcb375f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-2.4M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-026260 |
| FY 2022 | $-3.5M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-011692 |
| FY 2021 | $3.6M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-007249 |
| FY 2020 | $1.6M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008834 |
| FY 2017 | $-7.9M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-004485 |
| FY 2016 | $-19.8M | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-003099 |
| FY 2015 | $-16.9M | 2015-01-01 – 2015-12-31 | evidence 0001493152-16-008400 |
| FY 2014 | $-49.9M | 2014-01-01 – 2014-12-31 | evidence 0001354488-15-001524 |
| FY 2013 | $-106.1M | 2013-01-01 – 2013-12-31 | evidence 0001354488-14-001571 |
| FY 2012 | $-175.0M | 2012-01-01 – 2012-12-31 | evidence 0001354488-14-001571 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).